Member Info for MrJinx

Lol…what extra research do I need to do?

Q. Is there an effective allogeneic treatment for R/R AML?

A. No

End of research

…and to expand on your cautionary not One4One, that AML patients don’t have the luxury of time, why then do you keep posting 💩 about an allogeneic treatment which could be decades away?

Let’s hope that Hemo’s treatment is as effective as most of us wish, but I also hope that it becomes either a first line treatment because it’s so effective, or that in time, it becomes obsolete because of another huge breakthrough in future treatments. But in the meantime, HG-CT1 ‘IS’ the hopeful breakthrough treatment, at this time.

@Kingping25 - Thanks for the update mate. Quite why nobody else could state that without throwing a big girl’s hissy fit about ‘traders’, is a mystery.

Oh do keep up ConsDoms, even JHFH has admitted there has been a delay.

The reason or at least acknowledgment that there is a delay. It’s not too much to ask.

Three or four weeks ago there were denials from all quarters that there was a delay, and I was the ba’stard du jour for even raising the subject. If there’s one thing that grinds my nuts is people trying to gaslight. Just be open and honest.

@BBB11 - You’re not wrong about the toxicity of this board. I’ll admit I have played a small role in that. However, these disagreements and gripes are fertilised by the absolute void that is Hemo investor relations. Quite frankly there’s a palpable arrogance and disdain by the Hemo BoD that is incredibly difficult to comprehend. So, in the absence of information, guesswork, rumour and discontent fills the void.

I can’t wait for the influx of buying trades after the huge news from yesterday’s agm… 👀

So, was Vlad there in person yesterday, or through teams?

‘Confirmed’? You mean someone actually asked ‘are we going to be rich soon’? 🤣

Apparently, tomorrow it’s going to pish down diamonds, so get your buckets ready…or some other 💩 that they can think of.

The usual fools with their dodgy claims. I just wish Hemo were more professional than they are being. They’re a PLC ffs!

Well I hope it’s very VERY exciting, because I want to pile into gold. China making moves.

It was strangely Chuckey’esque.

@PurpleKenny - there couldn’t have been much to report.

Let’s chew through their answers;

Q. What’s the delay? A. There is no delay, everything is tickety-boo and anything of concern would be RNS’d

Q. Are the first three patients still alive? A. Obviously, we’re in the middle of a clinical trial and once trial results are confirmed and ratified, they will be released to the public. Also, we need to be sensitive to both the patients and their families.

Q. Why did Peter Redmond get such a huge glut of options? A. Peter has been with us from the start and we are where we because of his hard work and experience helping Hemo to navigate difficult circumstances during what are tight financial constraints for funding.

Q. Why aren’t there any sandwiches. A. Naturally, every penny counts so why would we put a spread on for ungrateful private investors, when we’re trying to save lives?

“If that’s all the questions, we’re off back to our five star hotel for afternoon tiffin”

But you think Avacta will be sold for £40bn. 😂🤣😂🤣

Clown 🤡

Blastoid, you should read the posts before assuming any of us have said it’s a lost cause. I certainly haven’t but the delay is an appropriate point of contention to be discussed on a discussion board, don’t you think?

Well I’m working. Unfortunately, I was expecting to have retired on my Hemo riches by now. 🤑

You do have to wonder though, whilst we’re all being kept guessing, why would the BoDs award themselves a stonking great mass of options at £8, if there’s information that could make the S.P tank? Logically, it doesn’t make sense, but then Vlad and PR have never done logic.

Aldemoron, yer a feckin idiot. Read the RNS’. None of the three previously treated patients suffered a serious adverse event because of HG-CT1. You say “ It may be unrelated, it may not be classed as a DLT…” but if that’s the case, it’s irrelevant to the trial. If P1 has died, it’s a serious adverse event to them, but is not relevant to the initial safety stage of the trial. They certainly wouldn’t have received clearance for kids, that is for sure.

However, that’s not to say they’re not struggling to recruit trial subjects. If that’s the case then this should be RNS’d at some point as it affects the stated number of patients treated over the given time frame of 12 - 18 months.

I cautioned about four weeks ago that something wasn’t quite right and I was called all sorts by the unthinking throb. But then what happens, JHFH admits there’s a delay and all of them slink away. Except Chucky of course. He still thinks this is all part of Vlad’s great plan and this delay is because Hemo are going to announce a multi-billion dollar deal just before the agm. Give him his dues, he is loyal, like a puppy 🐶

Anyway Aldemoron, if you’re going to spread shiite, at least try using facts.

Oh look, Chucky giving it the big ‘un. 😂

Coming up to eleven months since P3 treated.